Today: 29 April 2026
Morgan Stanley stock jumps nearly 6% after earnings beat and dividend lift
15 January 2026
1 min read

Morgan Stanley stock jumps nearly 6% after earnings beat and dividend lift

New York, January 15, 2026, 13:12 ET — Regular session.

  • Morgan Stanley shares climbed 5.9% in afternoon trading following their quarterly earnings report
  • Bank posted earnings per share of $2.68 and announced a quarterly dividend of $1.00
  • Investors focus sharply on the rebound in investment banking and the deal pipeline slated for 2026

Morgan Stanley shares climbed 5.9% to $191.39 in Thursday afternoon trading, swinging between $178.70 and $191.94 as investors digested the bank’s quarterly results.

The report arrives just as bank earnings season morphs into a fast-paced test of whether dealmaking is truly rebounding or merely surged late last year. For Morgan Stanley, this question carries extra weight since its profits closely track underwriting and advisory fees during market upswings.

Investors remain divided on interest rates. While lower rates could boost issuance and spark deal activity, they also alter how clients handle cash and can quickly shift trading volumes.

Morgan Stanley reported fourth-quarter net revenue of $17.9 billion and earnings of $2.68 per share. Its return on tangible common equity, which excludes goodwill and other intangibles, came in at 21.8%. The bank also repurchased $1.5 billion of common stock during the quarter and announced a $1.00 quarterly dividend, payable February 13 to shareholders of record on January 30.

The stock surged after a profit beat driven largely by investment banking, where revenue climbed 47% to $2.41 billion, boosted by nearly double the debt underwriting, Reuters reports. CFO Sharon Yeshaya told Reuters, “We are seeing an accelerating pipeline in M&A and IPOs.” CEO Ted Pick added the bank plans to “continue to be patient” on acquisitions, despite what he called excess capital. Reuters

Morgan Stanley’s report arrived as Goldman Sachs posted robust results, highlighting a boost in mergers and underwriting expected to drive growth into late 2025. The key question for the sector is whether fee growth can sustain itself after the busy start-of-year pipeline of deals and listings plays out in actual markets.

Investors will be parsing which elements of the quarter can be relied upon and which were just timing — like deal closings, underwriting windows, and a market that can shift on a single bad week. The wealth business aims to steady things, but it doesn’t completely shield the stock when risk appetite wanes.

Still, the setup is vulnerable. Should equity markets falter or volatility surge, IPOs could stall, bond issuance might freeze, and advisory fees could vanish fast — hitting the very businesses that fueled the recent upside surprise.

Coming next is the big macro event: the Federal Reserve’s January 27-28 meeting. It has the power to shift rate-cut expectations and influence client activity as well as trading environments for banks heading into the next quarter.

Stock Market Today

  • Magnificent Seven Earnings, Fed Meeting, and Market Turmoil Mark Key Trading Day
    April 29, 2026, 10:07 AM EDT. Wingstop stock dropped over 10% pre-market following an 8.7% fall in same store sales and cautious guidance. Despite the setback, the company expands store counts and remains optimistic long-term. The S&P 500 wavered amid rising geopolitical tensions, as President Trump ordered an extended blockade of Iranian ports, pushing Brent crude oil up 3% to $114. Market focus also centers on Federal Reserve Chair Jerome Powell's final meeting before successor Kevin Warsh takes over. Investors await earnings from tech giants Alphabet, Amazon, Meta, and Microsoft to assess the payoff of their AI investments. Semiconductor firms Seagate and NXP surged 12% and 19%, fueled by AI infrastructure demand. Oil traders price in a "war premium" due to sharply reduced Strait of Hormuz shipping volume. Additionally, OpenAI's reported missed targets sparked a selloff in Nvidia and related stocks, despite company denials.

Latest article

Lemonade Stock Jumps as Q1 Revenue Surge Sharpens Its 2026 Profit Test

Lemonade Stock Jumps as Q1 Revenue Surge Sharpens Its 2026 Profit Test

29 April 2026
Lemonade Inc reported first-quarter revenue of $258 million, up 71% from a year earlier, and narrowed its net loss to $35.8 million, or 47 cents a share. Shares rose 5.6% in premarket trading after results beat estimates. In-force premium climbed 32% to $1.33 billion, with customers up 23% to 3.14 million. The company raised its 2026 outlook and now expects full-year revenue of up to $1.203 billion.
Biogen Cuts 2026 Profit Forecast After Q1 Beat as Leqembi Sales Surge

Biogen Cuts 2026 Profit Forecast After Q1 Beat as Leqembi Sales Surge

29 April 2026
Biogen lowered its 2026 adjusted earnings forecast to $14.25–$15.25 per share, citing research and development charges from recent acquisitions. First-quarter revenue rose 2% to $2.48 billion, with adjusted earnings of $3.57 per share, beating analyst estimates. Leqembi sales climbed 74% to $168 million globally.
Visa Stock Jumps as Earnings Beat and $20 Billion Buyback Ease Spending Fears

Visa Stock Jumps as Earnings Beat and $20 Billion Buyback Ease Spending Fears

29 April 2026
Visa shares jumped 5% premarket Wednesday after the company beat quarterly profit estimates, raised its full-year outlook, and announced a $20 billion buyback. Adjusted net income rose to $6.3 billion, or $3.31 a share, topping forecasts. Payments volume climbed 9%, cross-border volume 12%. Visa cited resilient consumer spending but flagged Middle East tensions as a risk to travel flows.
Pfizer stock dips as U.S. vaccine policy fight rattles demand outlook
Previous Story

Pfizer stock dips as U.S. vaccine policy fight rattles demand outlook

XRP stock slides as Senate delays key crypto bill vote; what traders watch next
Next Story

XRP stock slides as Senate delays key crypto bill vote; what traders watch next

Go toTop